A Study of Acute Myocardial Infarction Using FDY-5301
Status:
Completed
Trial end date:
2019-01-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics (PK) of
three dose levels of FDY-5301 compared to placebo in STEMI patients undergoing PCI.